Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Forma

“From the aesthetics to the feel and the sounds, the Sferata is wholly convincing”: Rivolta Forma Sferata review

Just because Rivolta is Dennis Fano's more affordable brand doesn't mean he keeps his best ideas for Novo...

Guitar World

‘It’s already way beyond what humans can do’: will AI wipe out architects?

It’s revolutionising building – but could AI kill off an entire profession? Perhaps not, finds our writer, as he enters a world where Corbusier-style marvels and 500-room hotels are just a click away

The Guardian - UK

A man with a knife in his back: Oliver Frank Chanarin’s best photograph

‘The Casualties Union act out injuries for hospitals, emergency services – and police preparing for suicide attacks. Their work requires precision performance’

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

3 High-Quality Stocks to Pick up in 2023

With slowing inflation, resilient economic growth, and a robust labor market aided by a slower rate hike by the Fed, fundamentally strong stocks Exxon Mobil (XOM), Novo Nordisk (NVO), and Bridgestone (BRDCY) seem to be good investments now. Continue reading….

StockNews.com

Nottingham Morphe store remains open despite US retail turmoil

All US stores closed earlier this month unexpectedly

Nottingham Post

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout

Novo Nordisk said Thursday it will spend $1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Home of Liverpool Echo sold after hitting the market for almost £35m

European Fund Manager Forma Real Estate has bought the building from abrdn

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Exxon Mobil Corporation

49 stories

Regeneron Pharmaceuticals Inc

43 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.